A newly introduced bill from Rep. Chris Collins (R-NY) would impose user fees on hospitals participating in the 340B Drug Pricing Program.
Full text of the Drug Discount Accountability Act, H.R. 6240, has yet to be released, but the bill also is expected to require hospitals to report their total 340B purchases.
The association is tracking this and several other draft bills related to 340B that are expected to be introduced this year. We will continue to update our members on developments.
Markup of Hospital Preparedness, GME Bills
Meanwhile, the House Committee on Energy and Commerce Subcommittee on Health held a markup of multiple public health measures, including the reauthorization of the Pandemic and All-Hazards Preparedness Act of 2018 (PAHPA). The PAHPA reauthorization bill passed by the subcommittee would reauthorize just under $265 billion annually in funding for the Hospital Preparedness Program for fiscal years 2019 through 2023.
The subcommittee also marked up the Children’s Hospital Graduate Medical Education (CHGME) Support and Re-authorization Act of 2018, H.R. 5385. The bill would reauthorize $220 billion annually in funding for the CHGME program for fiscal years 2019 through 2023.
Both PAHPA and the CHGME reauthorization now move to the full committee for consideration after the July Fourth recess.